Postmenopausal Vaginal Atrophy Drugs and Forecast Market

List of Tables
Table 1. Key Players of Postmenopausal Vaginal Atrophy Drugs in Global Market
Table 2. Top Postmenopausal Vaginal Atrophy Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Postmenopausal Vaginal Atrophy Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Postmenopausal Vaginal Atrophy Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Postmenopausal Vaginal Atrophy Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Postmenopausal Vaginal Atrophy Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Postmenopausal Vaginal Atrophy Drugs Product Type
Table 9. List of Global Tier 1 Postmenopausal Vaginal Atrophy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Postmenopausal Vaginal Atrophy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2024-2029
Table 46. Actavis plc Company Summary
Table 47. Actavis plc Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 48. Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Actavis plc Key News & Latest Developments
Table 50. Bionovo, Inc. Company Summary
Table 51. Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 52. Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Bionovo, Inc. Key News & Latest Developments
Table 54. Endoceutics, Inc. Company Summary
Table 55. Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 56. Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Endoceutics, Inc. Key News & Latest Developments
Table 58. Novo Nordisk A/S Company Summary
Table 59. Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 60. Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Novo Nordisk A/S Key News & Latest Developments
Table 62. Pfizer Inc. Company Summary
Table 63. Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 64. Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Pfizer Inc. Key News & Latest Developments
Table 66. Teva Pharmaceuticals Ltd. Company Summary
Table 67. Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 68. Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Teva Pharmaceuticals Ltd. Key News & Latest Developments
Table 70. Therapeutics MD, Inc. Company Summary
Table 71. Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 72. Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Therapeutics MD, Inc. Key News & Latest Developments
Table 74. Shionogi & Company Company Summary
Table 75. Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 76. Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Shionogi & Company Key News & Latest Developments
Table 78. Allergan plc Company Summary
Table 79. Allergan plc Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 80. Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Allergan plc Key News & Latest Developments
Table 82. Shionogi & Co. Ltd. Company Summary
Table 83. Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 84. Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Shionogi & Co. Ltd. Key News & Latest Developments
Table 86. Postmenopausal Vaginal Atrophy Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Postmenopausal Vaginal Atrophy Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Postmenopausal Vaginal Atrophy Drugs Production by Region, 2018-2023 (K Units)
Table 89. Global Postmenopausal Vaginal Atrophy Drugs Production by Region, 2024-2029 (K Units)
Table 90. Postmenopausal Vaginal Atrophy Drugs Market Opportunities & Trends in Global Market
Table 91. Postmenopausal Vaginal Atrophy Drugs Market Drivers in Global Market
Table 92. Postmenopausal Vaginal Atrophy Drugs Market Restraints in Global Market
Table 93. Postmenopausal Vaginal Atrophy Drugs Raw Materials
Table 94. Postmenopausal Vaginal Atrophy Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Postmenopausal Vaginal Atrophy Drugs Downstream
Table 96. Postmenopausal Vaginal Atrophy Drugs Downstream Clients in Global Market
Table 97. Postmenopausal Vaginal Atrophy Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Postmenopausal Vaginal Atrophy Drugs Segment by Type in 2022
Figure 2. Postmenopausal Vaginal Atrophy Drugs Segment by Application in 2022
Figure 3. Global Postmenopausal Vaginal Atrophy Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Postmenopausal Vaginal Atrophy Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Postmenopausal Vaginal Atrophy Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Postmenopausal Vaginal Atrophy Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Postmenopausal Vaginal Atrophy Drugs Revenue in 2022
Figure 9. By Type - Global Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Postmenopausal Vaginal Atrophy Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Postmenopausal Vaginal Atrophy Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2018-2029
Figure 23. US Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2018-2029
Figure 28. Germany Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2018-2029
Figure 37. China Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Postmenopausal Vaginal Atrophy Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Postmenopausal Vaginal Atrophy Drugs by Region, 2022 VS 2029
Figure 54. Postmenopausal Vaginal Atrophy Drugs Industry Value Chain
Figure 55. Marketing Channels